Novel trans-2,3-enoyl-CoA reductase–like variant associated with catecholaminergic polymorphic ventricular tachycardia type 3
| dc.contributor.author | Charafeddine, Fatme | |
| dc.contributor.author | Assaf, Nada P. | |
| dc.contributor.author | Ismail, Ali | |
| dc.contributor.author | Bulbul, Ziad R. | |
| dc.contributor.department | Pediatrics and Adolescent Medicine | |
| dc.contributor.department | Pathology and Laboratory Medicine | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T12:11:24Z | |
| dc.date.available | 2025-01-24T12:11:24Z | |
| dc.date.issued | 2023 | |
| dc.identifier.doi | https://doi.org/10.1016/j.hrcr.2022.12.013 | |
| dc.identifier.eid | 2-s2.0-85145703053 | |
| dc.identifier.uri | http://hdl.handle.net/10938/32556 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Inc. | |
| dc.relation.ispartof | HeartRhythm Case Reports | |
| dc.source | Scopus | |
| dc.subject | Cpvt | |
| dc.subject | Inherited channelopathy | |
| dc.subject | Long qt syndrome | |
| dc.subject | Sudden cardiac death | |
| dc.subject | Tecrl | |
| dc.subject | Flecainide | |
| dc.subject | Nadolol | |
| dc.subject | Oxidoreductase | |
| dc.subject | Propranolol | |
| dc.subject | Trans 2,3 enoyl coa reductase | |
| dc.subject | Unclassified drug | |
| dc.subject | Adolescent | |
| dc.subject | Article | |
| dc.subject | Cardiovascular magnetic resonance | |
| dc.subject | Case report | |
| dc.subject | Catecholaminergic polymorphic ventricular tachycardia | |
| dc.subject | Child | |
| dc.subject | Clinical article | |
| dc.subject | Clinical feature | |
| dc.subject | Disease association | |
| dc.subject | Dizziness | |
| dc.subject | Echocardiography | |
| dc.subject | Electrical storm (heart) | |
| dc.subject | Electrophysiology | |
| dc.subject | Exercise test | |
| dc.subject | Family history | |
| dc.subject | Female | |
| dc.subject | Follow up | |
| dc.subject | Frameshift mutation | |
| dc.subject | Genetic variation | |
| dc.subject | Heart palpitation | |
| dc.subject | Heart ventricle extrasystole | |
| dc.subject | Heart ventricle function | |
| dc.subject | Heterozygosity | |
| dc.subject | Holter monitoring | |
| dc.subject | Homozygosity | |
| dc.subject | Human | |
| dc.subject | Low drug dose | |
| dc.subject | Medication compliance | |
| dc.subject | Mitral valve prolapse | |
| dc.subject | Mitral valve regurgitation | |
| dc.subject | Nausea | |
| dc.subject | Physiological stress | |
| dc.subject | Preschool child | |
| dc.subject | Primary prevention | |
| dc.subject | Qt prolongation | |
| dc.subject | School child | |
| dc.subject | Sport | |
| dc.subject | T wave | |
| dc.subject | Whole exome sequencing | |
| dc.title | Novel trans-2,3-enoyl-CoA reductase–like variant associated with catecholaminergic polymorphic ventricular tachycardia type 3 | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1